(Q42162410)
Statements
Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) study (English)
F Depont
A Fourrier
Y Merlière
C Droz
M Amouretti
B Bégaud
J Bénichou
Y Moride
G P Velo
M Sturkenboom
N Moore